Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results (Q43594172)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results |
scientific article |
Statements
1 reference
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results (English)
1 reference
M Duvic
1 reference
K Hymes
1 reference
P Heald
1 reference
D Breneman
1 reference
A G Martin
1 reference
P Myskowski
1 reference
C Crowley
1 reference
R C Yocum
1 reference
Bexarotene Worldwide Study Group
1 reference
1 May 2001
1 reference
1 reference
Identifiers
1 reference